![Arul Chinnaiyan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Arul Chinnaiyan
Corporate Officer/Principal bei University of Michigan
Aktive Positionen von Arul Chinnaiyan
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
University of Michigan | Corporate Officer/Principal | 11.03.2010 | - |
Brightedge Ventures
![]() Brightedge Ventures Investment ManagersFinance Brightedge Ventures (Brightedge Ventures) is a venture capital subsidiary of American Cancer Society, Inc founded in 2018. The firm is headquartered in Atlanta, Georgia. | Berater | - | - |
Karriereverlauf von Arul Chinnaiyan
Ehemalige bekannte Positionen von Arul Chinnaiyan
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Lynx Dx, Inc.
![]() Lynx Dx, Inc. Medical SpecialtiesHealth Technology Lynx Dx, Inc. provides health care services. It focuses on commercializing diagnostic tools. The company is headquartered in Ann Arbor, MI. | Direktor/Vorstandsmitglied | - | - |
Präsident | - | - | |
Oncofusion Therapeutics, Inc.
![]() Oncofusion Therapeutics, Inc. BiotechnologyHealth Technology Oncofusion Therapeutics, Inc. operates as oncology development company. It specializes in BET Bromodomain Inhibitors, ERG Inhibitors, EZH2-EED Inhibitors and MMSET/NSD2 Inhibitors. The company was founded in 2012 by Arul M. Chinnaiyan and Shaomeng Wang and is headquartered in Ann Arbor, MI. | Gründer | 01.01.2012 | - |
Statistik
International
Vereinigte Staaten | 5 |
Operativ
Corporate Officer/Principal | 1 |
Founder | 1 |
Director/Board Member | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 2 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Oncofusion Therapeutics, Inc.
![]() Oncofusion Therapeutics, Inc. BiotechnologyHealth Technology Oncofusion Therapeutics, Inc. operates as oncology development company. It specializes in BET Bromodomain Inhibitors, ERG Inhibitors, EZH2-EED Inhibitors and MMSET/NSD2 Inhibitors. The company was founded in 2012 by Arul M. Chinnaiyan and Shaomeng Wang and is headquartered in Ann Arbor, MI. | Health Technology |
Brightedge Ventures
![]() Brightedge Ventures Investment ManagersFinance Brightedge Ventures (Brightedge Ventures) is a venture capital subsidiary of American Cancer Society, Inc founded in 2018. The firm is headquartered in Atlanta, Georgia. | Finance |
Lynx Dx, Inc.
![]() Lynx Dx, Inc. Medical SpecialtiesHealth Technology Lynx Dx, Inc. provides health care services. It focuses on commercializing diagnostic tools. The company is headquartered in Ann Arbor, MI. | Health Technology |
- Börse
- Insiders
- Arul Chinnaiyan
- Erfahrung